Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies

NCT04883957 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Mature B-cell Malignancies

Interventions

DRUG: BGB-11417

Sponsor

BeiGene